Research Article
The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer
Table 1
Clinicopathological correlations of SLDH in gastric cancer.
| Variable | Normal SLDH (342) (%) | High SLDH (23) (%) | |
| Age (y) | | | 0.675 | <60 | 208 (93.3) | 15 (6.7) | | ≥60 | 134 (94.4) | 8 (5.6) | | Gender | | | 0.610 | Male | 226 (94.2) | 14 (5.8) | | Female | 116 (92.8) | 9 (7.2) | | Tumor size (cm) | | | 0.252 | ≤4 | 181 (92.3) | 15 (7.7) | | >4 | 161 (95.3) | 8 (4.7) | | Borrmann type | | | 0.092 | I | 9 (81.8) | 2 (18.2) | | II | 68 (97.1) | 2 (2.9) | | III | 226 (94.2) | 14 (5.8) | | IV | 39 (88.6) | 5 (11.4) | | Histological type | | | 0.521 | Well diff. ade. | 6 (85.7) | 1 (14.3) | | Moderately diff. ade. | 80 (96.4) | 3 (3.6) | | Poorly diff. ade. | 249 (92.9) | 19 (7.1) | | Undifferentiated ade. | 4 (100) | 0 (0) | | Squamous cell ca. | 3 (100) | 0 (0) | | pT stage | | | 0.011* | T1 | 31 (96.9) | 1 (3.1) | | T2 | 29 (100) | 0 (0) | | T3 | 222 (95.3) | 11 (4.7) | | T4 | 60 (84.5) | 11 (15.5) | | pN stage | | | 0.106 | N0 | 82 (97.6) | 2 (2.4) | | N1 | 148 (94.3) | 9 (5.7) | | N2 | 72 (92.3) | 6 (7.7) | | N3 | 40 (97.0) | 6 (1.3) | | Metastasis | | | 0.012* | No | 279 (95.5) | 13 (4.5) | | Yes | 63 (86.3) | 10 (13.7) | | pTNM stage | | | 0.001* | I | 41 (97.6) | 1 (2.4) | | II | 54 (94.7) | 3 (5.3) | | III | 155 (97.5) | 4 (2.5) | | IV | 92 (86.0) | 15 (14.0) | | Recurrence | | | 0.012* | No | 210 (96.3) | 8 (3.7) | | Yes | 132 (89.8) | 15 (10.2) | |
|
|
SLDH: serum lactate dehydrogenase; ade.: adenocarcinoma; diff.: differentiated; ca.: carcinoma; .
|